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Root bark preparation of Annona senegalensis Pers. (Annonaceae) is used in Nigerian ethnomedicine for treatment of infectious
diseases. Extraction of the A. senegalensis powdered root bark with methanol-methylene chloride (1:1) mixture yielded the
methanol-methylene extract (MME) which was fractionated to obtain the ethyl acetate fraction (EF). The EF on further
fractionation gave two active subfractions, F1 and F2. The F1 yielded a lipophilic oily liquid while F2 on puriﬁcation,
precipitated white crystalline compound, AS2. F1 was analyzed using GC-MS, while AS2 was characterized by proton
NMR and X-ray crystallography. Antibacterial and antifungal studies were performed using agar-well-diﬀusion method with
0.5 McFarland standard and MICs calculated. GC-MS gave 6 major constituents: kaur-16-en-19-oic acid; 1-dodecanol; 1-
naphthalenemethanol; 6,6-dimethyl-bicyclo[3.1.1]hept-2-ene-2-ethanol; 3,3-dimethyl-2-(3-methylbuta-1,3-dienyl)cyclohexane-
1-methanol; 3-hydroxyandrostan-17-carboxylic acid. AS2 was found to be kaur-16-en-19-oic acid. The MICs of EF, F1, and AS2
againstB.subtiliswere180,60,and30µg/mL,respectively.AS2exhibitedactivityagainstS.aureuswithanMICof150µg/mL,while
F1 was active against P. aeruginosa with an MIC of 40µg/mL. However, the extracts and AS2 exhibited no eﬀects against Candida
albicans and Aspergillus niger. Therefore, kaurenoic acid and the lipophilic fraction from A. senegalensis root bark exhibited potent
antibacterial activity.
1.Introduction
The increase in the incidence of new and reemerging infec-
tious diseases caused by organisms with high resistance rates
to standard antimicrobial agents has been a very challenging
and global health burden. The indiscriminate and wide-
spread antimicrobial use continues to cause signiﬁcant in-
crease in drug-resistant and multidrug-resistant bacteria
[1, 2]. Medicinal plants have long been used in traditional
medicine for treatment of various ailments including infec-
tious diseases and many potent phytochemicals or second
-ary metabolites possessing antimicrobial eﬀects have been
isolated from plants [3, 4]. These constituents could serve as
veritable lead compounds in the science of drug discovery,
development, and research. An example is the startling
discovery of penicillin from a microscopic plant in 1928 that
lead to the synthesis of its derivatives such as penicillin G
[5]. It is quite pertinent to note that since the discovery of
nalidixic acid in 1962, which led to the synthesis of more
potent ﬂuoroquinolones and derivatives [6], there has not
been the introduction of any major pharmacological class of
antibacterial agents. Hence, this is posing a great challenge to
researchers in the area of drug discovery and development
of anti-infective agents and has equally lend credence to2 Evidence-Based Complementary and Alternative Medicine
the intensiﬁed research going on in the area of natural
products for the isolation of potent compounds that could
serve as lead in the discovery of new antibacterial agents [7].
Screening of medicinal plants and other natural products
has led to the isolation of clinically active antibacterial
agents [8]. Interestingly, many plant extracts have shown to
possessantimicrobialeﬀectsandarebeingusedintraditional
medicine [9, 10]. Annona senegalensis Pers. (Annonaceae) is
among the medicinal plants that have been documented to
possess antibacterial eﬀects [11–13]. Also the ethnomedic-
inal uses of the plant in the treatment of wounds and
infectious diseases such as diarrhea [14, 15] periodontal and
other oral infections [16] had been reported. Furthermore,
the anticonvulsant, sedative, and muscle relaxant [17, 18]a s
wellasanti-inﬂammatory[19]eﬀectsoftherootbarkextract
and fractions of A. senegalensis have been reported.
Therefore, the objective of this study was to ascertain the
antimicrobial eﬀects of the root bark extracts and fractions
of A. senegalensis and to isolate and characterize the active
phytochemical(s) responsible for these eﬀects using proton-
NMR and X-ray crystallography.
2.MaterialsandMethods
2.1. Plant Materials. Fresh roots of A. senegalensis were col-
lected from Enugu-Ezike, Enugu State, Nigeria in the month
of June, 2007 and authenticated by a taxonomist, Mr. A.
O. Ozioko, of the International Centre for Ethnomedicine
and Drug Development (InterCEDD), Aku Road, Nsukka,
Enugu State, Nigeria. A voucher specimen was deposited
at the InterCEDD herbarium (specimen number: BDCP
/INTERCEED–64).
2.2. Test Organisms. Clinical strains of Escherichia coli, Bacil-
lus subtilis, Pseudomonas aeruginosa, Salmonella paratyphi
and Staphylococcus aureus, Aspergillus, niger and Candida
albicans, obtained from the Medical Laboratory Department
of Bishop Shanahan Memorial Hospital, Nsukka, Enugu
State, Nigeria and preserved in the Microbiology Unit of the
Department of Pharmaceutics and Pharmaceutical Micro-
biology, University of Nigeria, Nsukka, were used. These
clinicalstrainswereisolatedfromdesignatedbiologicalﬂuids
or sources as shown in Table 1.
2.3.Animals. Adultalbinomice(18–30g;n = 14)bredinthe
LaboratoryAnimalFacilityoftheDepartmentofPharmacol-
ogyandToxicology,UniversityofNigeria,Nsukka,wereused
in the studies. The animals were maintained under standard
laboratory conditions and had free access to standard pellets
(Guinea Feeds, Nigeria Plc) and water. On transfer to the
work area, animals were allowed two weeks of acclimati-
zation before the commencement of the experiments. All
animal experiments were conducted in compliance with the
National Institute of Health Guidelines for Care and Use of
Laboratory Animals (Publication no. 85–23, revised 1985)
and approval of the University Ethical Committee on the use
of laboratory animals.
Table 1: Biological sources of clinical strains of the test organisms.
S/No Clinical strain Biological
source
1 Bacillus subtilis Wound
2 Escherichia coli Stool
3 Pseudomonas
aeruginosa Wound
4 Salmonella paratyphi Stool
5 Staphylococcus aureus Nasal discharge
6 Aspergillus niger Spoiled food
7 Candida albicans High vaginal
swab (HVS)
2.4. Preparation and Extraction of Plant Materials. The root
barks were peeled oﬀ, cut into pieces, and dried under shade.
The dried root-bark was then pulverized into coarse powder
using a hammer mill. The powdered material (2.95kg) was
extracted with a mixture of methanol: methylene chloride
(1:1) using Soxhlet extractor to obtain the methanol:
methylene chloride extract or the crude extract (MME).
This was concentrated at reduced pressure using a rotary
evaporator to obtain a yield of 375g (12.71% w/w).
2.5. Solvent-Guided Fractionation of MME and Bioactivity-
Guided Studies. The methanol-methylene chloride extract
(MME; 250g) was subjected to solvent-guided fractionation
in a silica gel (70-220 mesh, Merck Germany) column, suc-
cessivelyelutedwithn-hexane,ethylacetate,andmethanolin
order of increasing polarity. The fractions were concentrated
under reduced pressure in a rotary evaporator (below 40◦C)
to obtain the hexane fraction (HF; 115g; 46.0% w/w),
ethyl acetate fraction (EF; 61g; 24.4% w/w), and methanol
fraction (MF; 69.5g; 27.8% w/w). Bioactivity-guided studies
on the extract and fractions using agar well diﬀusion
method showed that EF had a potent antibacterial activity
with a relatively higher inhibition zone diameter (IZD)
than the HF and MF. Subsequently, the ethyl acetate (EF)
s o l u b l ef r a c t i o nw a ss u b j e c t e dt oc o l u m nc h r o m a t o g r a p h i c
separation. The EF (50g) was separated in a dry-packed
silica gel (70–220 mesh, Merck Germany) column of width
4cm and length 40cm. The extract was mixed with the
silica gel and loaded on top of the prepacked column.
The column was successively eluted with gradient mixtures
of n-hexane and ethyl acetate (1:0, 9:1, 8:2, 7:3, 6:4,
5:5, 4:6, 3:7, and 2:8) and the fractions collected in
500mL volume. The fractions were subsequently pooled and
concentrated to aﬀord eight broad fractions, F1–F8, based
on the similarity of constituents visualized on silica gel pre-
coated TLC plates (Uniplate-Analtech Co., USA), developed
with mixtures of n-hexane and ethyl acetate accordingly.
FractionF1gaveanoilyliquidorlipophilicfraction,whileF2
(9–12; 2000mL) when concentrated yielded white crystals.
However, the crystals yielded by F2 were harvested and
puriﬁed by repeated washing with n-hexane and dried to
obtain A. senegalensis crystals (AS2) (2.8g; 5.6% w/w) which
was stored in a refrigerator for activity studies.Evidence-Based Complementary and Alternative Medicine 3
2.6. Phytochemical Tests. The preliminary phytochemical
analysis of methanol-methylene chloride extract (MME),
ethyl acetate fraction (EF), hexane fraction (HF), methanol
fraction (MF), and ethyl acetate subfraction isolated com-
pound, AS2 were performed using standard phytochemical
procedures as described by Harborne [20] and Trease and
Evans [21]. Brieﬂy, frothing test for saponins, Salkowski test
forterpenoids,Liebermann-Burchardtestsforsteroids,ferric
chloridetestfortannins,Keller-Killianitestforcardiacglyco-
sides, Dragendorﬀ’s and Mayer’s test for alkaloids, Fehling’s
test for reducing sugars, xanthoproteic test for proteins,
iodine test for carbohydrates or starch, and ammonia test
for detection of ﬂavonoids were performed for qualitative
identiﬁcation of the phytoconstituents present in [22]. All
reagents for the preliminary phytochemical analysis were
freshly prepared.
2.7. Identiﬁcation and Characterization of AS2. Structural
elucidation of the pure crystals, AS2, was performed using
proton NMR and X-ray crystallography, since the com-
pound is in crystal form. The melting point of AS2 was
also determined using an analog melting point apparatus
(Electrothermal, Cat. no. IA 6304, England). The identity
was established by comparison of the spectral data and X-ray
crystallography of previously published compounds [23].
2.8. Acute Toxicity and Lethality (LD50)T e s to fA S 2 . The oral
acute toxicity and lethality test (LD50) of the AS2 was per-
formed in mice using the method described by Lorke [24].
Brieﬂy, the test was performed in two stages. In stage one,
animals received oral administration of one of 10, 100, and
1000mg/kg (n = 3) of AS2 and observed for 24h for number
of deaths. Sinceno death occurredin anyof the groupsin the
ﬁrst stage of the test, in stage two of the test, 1600, 2900, and
5000mg/kg doses of the AS2 were administered to a fresh
batch of animals (n = 1) and was also monitored for 24h.
Since death occurred at the maximum dose (5000mg/kg),
the LD50 was estimated as the product of the square root of
the dose that recorded death and the dose that recorded no
death preceding it (in this case, 2900mg/kg dose). We have
estimated and reported the acute toxicities and lethality tests
of MME, EF, HF, and MF in a separate study [18].
2.9. GCMS Analysis of the Lipophilic Fraction (F1). The gas
chromatography mass spectrometry (GCMS) of F1, the
lipophilic subfraction, of the EF fractions was analyzed using
GCMS-QP2010 PLUS (SHIMADZU, JAPAN) in order to
characterizethelipophiliccomponents.SampleoftheF1was
suspended in 1mL of ethyl acetate (Merck, Germany) and
1:l of this solution was analyzed by the gas chromatography
coupled with mass spectrometry equipped with a fused
silica capillary column DB-5 (30m × 0.25mm × 0.25m).
The electron impact technique (70eV) was used with the
injector temperature at 240◦C and that of the detector at
230◦C. The carrier gas was helium at the working rate of
1.7mL/min. The column temperature was initially 60◦Ca n d
then was gradually increased at the rate of 3 ◦C/min up to
240◦C. For detection of the oil components, we used a ﬂame
ionization detector set up at 230◦C. The identiﬁcation of the
components of the lipophilic fraction was eﬀected through
comparisonofsubstancemassspectrumwith thedatabaseof
the GC/MS (NIST 62.lib), the literature, and retention index
[25, 26].
2.10. Antimicrobial Assay. Each of the extract (MME), frac-
tions(HF,EF,andMF),F1andAS2wasdissolvedindimethyl
sulfoxide (DMSO) to obtain 100mg/mL concentration.
Subsequently, the concentration was diluted to obtain 50, 25,
12.5,and6.25mg/mLforthedeterminationoftheminimum
inhibitory concentration (MIC) at the dose levels. Agar well
diﬀusion method as described in [27, 28]w a se m p l o y e d
for the assay. The test organisms, the clinical isolates, were
prepared with a 0.5 McFarland standard and subcultured at
37◦C and maintained on nutrient agar media for bacteria
and sabouraud agar media for fungi (Aspergillus niger and
Candida albicans). Petriplates containing 20mL of respective
medium were seeded with selected microbial strains and
incubated at 37◦C for 24 hours. Standard antimicrobial
agents used as positive controls were gentamycin (Lek,
Slovakia)andciproﬂoxacin(Medreich,India).After24hours
the inhibition zone diameters (IZD) were recorded and the
mean calculated. The minimum inhibitory concentrations
(MICs) were then determined at various dilutions by
extrapolationfromthegraphsofIZDsquared(IZD2)against
logarithm of the concentration.
2.11. Statistical Analysis. Data obtained were analysed by
SPSS (Version 14) using One-Way Analysis of Variance
(ANOVA) with Dunnet its test for multiple comparisons
with the control. Values are in mean ± SEM and were
considered signiﬁcant at P<0.05.
3. Results
3.1. Phytochemical Tests. Phytochemical tests of methanol-
methylene chloride extract (MME) gave positive reactions
with phytochemical reagents with respect to alkaloids, car-
bohydrates, ﬂavonoids, fats and oils, glycosides, reducing
sugars, resins, steroids, saponins, and terpenoids. The ethyl
acetate (EF) gave positive reactions for alkaloids, ﬂavonoids,
resins and terpenoids, while AS2 gave a strong positive reac-
tion with Salkowski test. The phytoconstituents of hexane
fraction (HF) and methanol fraction (MF) were also shown
(Table 2).
3.2. Acute Toxicity and Lethality (LD50)T e s to fA S 2 .The
m e d i u ml e t h a ld o s e( L D 50) of the AS2 was found to be
3800mg/kg in mice indicating the good level of safety.
3.3. Identiﬁcation and Characterization of AS2. The AS2 was
shown to be a white crystalline and odourless compound.
The results of the proton NMR and X-ray crystallography,
whencomparedwiththespectraldataofknowncompounds,
established the identity of AS2 to be kaur-16-en-19-oic acid
or kaurenoic acid, a diterpenoid, with the chemical structure4 Evidence-Based Complementary and Alternative Medicine
Table 2: Phytochemical constituents of extract and fractions.
Constituent MME EF HF MF AS2
Carbohydrate + −−+ −
A l k a l o i d ++++−
Reducing sugar + −−+ −
Glycoside + −−+ −
Saponins + −−+ −
Tannins −−−−−
Flavonoids + + −−−
R e s i n ++++−
F a t s a n d o i l s +++−−
Steroids + − ++−
T e r p e n o i d s+++++
Acidic
compounds ++−−−
+
= present; − = absent.
and X-ray crystallograph as shown (Figures 1, 2 and 3). The
melting point of AS2 was found to be 170–172◦C.
3.4. GCMS Analysis of the Lipophilic Fraction (F1). The
GCMS analysis of F1 revealed the presence of the fol-
lowing 6 major constituents which include kaur-16-en-
19-oic acid, 1-dodecanol, 1-naphthalenemethanol, 6,6-
dimethyl-bicyclo[3.1.1]hept-2-ene-2-ethanol,3,3-dimethyl-
2-(3-methylbuta-1,3-dienyl)cyclohexan-1-methanol, and 3-
hydroxyandrostan-17-carboxylic acid (Table 3). The chemi-
cal structures of these constituents are shown in Figure 4.
3.5. Antimicrobial Assay. The extract, fractions, and AS2
exhibited signiﬁcant antibacterial activity and are devoid
of any antifungal activity. The results of the inhibition
zone diameter (IZD) and MICs of the extract and fractions
revealed activity against gram-positive and gram-negative
organisms(Table 4).Theorderofpotencyagainstthevarious
bacteria isolates with respect to their MICs by the extract
and fractions was B. subtilis (AS2 > F1 > HF ≡ MF > EF
> MME), S. aureus (AS2 > MME), and P. aeruginosa (F1
> MME) (Table 5). The MME exhibited an MIC of 0.370,
8.75, 1.08, and 0.07mg/mL against the clinical isolates of B.
subtilis,S.aureus,P. aeruginosa,andS.typhi,respectively .The
extracts and isolate showed no antibacterial activity against
E. coli (Table 4) .Th eF 1ga v ea nM I Co f0 . 0 6a n d0 . 0 4m g / m L
against B. subtilis and P. aeruginosa,r e s p e c t i v e l y .A S 2h a s
potency against S. aureus and B. subtilis with an MIC of
0.15 and 0.03mg/mL, respectively, whereas EF oﬀered an
MICof0.18mg/mLagainstB.subtilis(Table 5).However,the
antifungal test for MME, EF, HF, MF, F1, and AS2 against A.
niger and C. albicans showed no activity.
4. Discussion
The antimicrobial eﬀects of the methanol-methylene chlo-
ride extract (MME), ethyl acetate fraction (EF), hexane
Figure 1: X-ray crystallograph of AS2.
HO
O Kaur-16-en-19-oic acid
Figure 2: Chemical structure of AS2.
fraction (HF), methanol fraction (MF), the lipophilic sub-
fraction (F1), and the isolated compound, AS2 exhibited
appreciable antibacterial eﬀects but are devoid of antifungal
activity. However, AS2 exhibited the lowest MIC value of
30µg/mL against B. subtilis and therefore exhibited the most
potent activity when compared to the extracts and fraction
of the root bark of A. senegalensis. The results of the protonEvidence-Based Complementary and Alternative Medicine 5
(3) Comment
(6) Site
(8) Author
Parameter Value Parameter Value
(1) Data ﬁle name H:/AS2-NIG/3/ﬁd
(2) Title AS2-NIG
(4) Origin Bruker BioSpin GmbH
(7) Spectrometer Spect
(9) Solvent CDCI3
(10) Temperature 298.2
(11) Pulse sequence zg30
(12) Experiment 1D
(13) Number of scans 8
(14) Receiver gain 362
(15) Relaxation delay 1.0000
(16) Pulse width 10.2500
(17) Acquisition time 3.9846
(18) Acquisition date 2010-10-03T10:48:06
(22) Lowest frequency −1640.8
(23) Nucleus 1H
(24) Acquired size 32768
(25) Spectral size 65536
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Figure 3: Spectral data analysis of AS2.
NMR and X-ray crystallography identiﬁed and characterized
AS2 to be a diterpene known as kaur-16-en-19-oic acid or
kaurenoic acid (KA). The melting point of AS2 was found to
be 170–172◦C which was of a comparable range with that of
kaurenoic acid from a diﬀerent source already reported [29].
In a separate study, the antibacterial eﬀects of the essential
oil from A. senegalensis have been reported [12]a n dm o r e
importantly the antibacterial activity of kaurenoic acid from
the root extract of another plant, Viguiera arenaria, has been
documented [30]. The extracts, F1 and the KA, exhibited
better antibacterial eﬀects against gram-positive organisms
such as B. subtilis and S. aureus, than the gram-negative rods
such as P. aeruginosa, S. paratyphi,a n dE. coli used in the
study.
Therefore, the antibacterial eﬀects of MME, EF, HF, MF,
F1, and AS2 against organisms such as P. aeruginosa and
S. aureus correlated with the ethnomedicinal use of the
plant in wound healing, since P. aeruginosa and S. aureus
had been implicated in the contamination of wounds and
boils [31]. The antibacterial activity against P. aeruginosa is
of interest because P. aeruginosa has been reported to be
resistant to many antibacterial agents and identiﬁed as
an opportunistic pathogen which causes complications in
immune-compromised patients [32]. The activity of root
barkextractsofA.senegalensisagainstS.aureushasalsobeen
documented in a separate study [13]. Moreover, according to
Apak and Olila [13], the root bark extract of A. senegalensis
exhibitednoactivityagainstE.coliwhichwasconsistentwith6 Evidence-Based Complementary and Alternative Medicine
Table 3: Chemical constituents of lipophilic fraction (F1).
S/No Chemical name Molecular
formula
Molecular
weight
Retention
(KOVAT’s)
index
MS ions/fragments (m/e)
01 1-dodecanol C12H26O 186 1457 27, 41, 55, 70, 83, 97,
111(112), 126, 140
02
6,6-dimethyl-bicyclo
[3.1.1]hept-2-ene-2-
ethanol
C11H18O 166 1290 27, 41 (43), 67, 79, 91, 105,
122, 151.
03 Kaur-16-en-18-oic acid C21H32O2 316 2056
27, 41, 55, 67, 79, 91, 105,
121, 133, 147, 159, 187,
213, 241, 257, 273, 301,
316.
04 1-naphthalenemethanol C15H26O 222 1685 27, 41, 55, 69, 81, 109, 124,
191, 222.
05
3,3-dimethyl-2-(3-
methylbuta-1,3-dienyl)
cyclohexan-1-methanol
C14H24O 208 1592 41, 55, 69, 81, 95, 109, 123,
139, 165, 177, 193.
06
3-hydroxyandrostan-17-
carboxylic
acid
C20H32O3 320 2375
43, 67, 79, 93, 108, 121,
135, 147, 161, 175, 194,
215, 233, 248, 287, 302.
HO
(1)
OH
(2)
O
(3)
−O
(4)
OH
(5)
HO
O OH
(6)
Figure 4: Chemical structures of GCMS constituents of F1.Evidence-Based Complementary and Alternative Medicine 7
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Table 5: Minimum inhibitory concentration (MIC) of extract and fractions.
ORGANISM MME MF HF EF F1 AS2 CIP GEN
B. subtilis 370.00 150.00 140.00 180.00 60.00 30.00 0.28 0.02
S. aereus 8750.00 + + + + 150.00 1.18 0.23
P. aeruginosa 1080.00 + + + 40.00 + 3.60 0.79
S. paratyphi 70.00 + + + + + 0.39 1.77
MIC values are in µg/mL.
the lack of activity of MME, EF, HF, MF, F1, and AS2 against
E. coli identiﬁed in this study.
In addition to the antibacterial action of KA, there
is the possibility of the presence of other phytochemicals
contributing to the antibacterial activity of the extracts and
fractions of A. senegalensis. This is more so since the
F1, which consisted 6 major constituents, together with
KA, exhibited potent antibacterial activity with an MIC of
40µg/mL against P. aeruginosa, whereas the kaurenoic acid
alone did not show appreciable activity against P. aeruginosa.
Hence, due to the presence of six major phytochemicals in
the GC-MS analysis of the F1, the observed antibacterial
eﬀectscouldbeattributedtothecombinedorsingleeﬀectsof
anyofthecompoundswhichincludekaur-16-en-19-oicacid,
1-dodecanol, 1-naphthalenemethanol, 6,6-dimethyl-bicyclo
[3.1.1] hept-2-ene-2-ethanol, 3,3-dimethyl-2-(3-methylbu-
ta-1,3-ienyl)cyclohexan-1-methanol, and 3-hydroxyandro-
stan-17-carboxylic acid. The presence of kaurenoic acid
among these compounds is of practical interest as it was
also established as the pure isolated compound, AS2. The
kaurenoic acid from the F1 gave the following mass ions
on fragmentation with the GCMS analysis: 316 (molecu-
lar ion), 301 (demethylation), and 273 (decarboxylation).
Notably, steroids, organic acids, and alcohols dominated the
remaining 5 compounds of the F1 and both organic acids as
well as alcohols are known to possess antibacterial activity
especially at higher concentrations [3]. However, F1 showed
a strong indication and possibility of being a ﬁxed oil, since it
possesses some characteristicsattributableto ﬁxed oils which
include odorless liquid at room temperature, pale yellowish
in colour, permanent grease spot on ﬁlter paper when
heated in an oven and often contains mixture of organic
acids as well as being an extraction product of n-hexane or
mixture of n-hexane and ethyl acetate [33]. Medicinal plants
with preponderance of variety of secondary metabolites,
such as tannins, terpenoids, essential oils, alkaloids, and
ﬂavonoids have been found in vitro, to possess antimicrobial
properties [3]. There is a recognizable loss of activity due to
fractionation as the crude extract, MME, exhibited activity
against all the organisms tested except E. coli, whereas the
fractions were found to have lost activity to some of the
tested organisms especially S. paratyphi.T h ep r e s e n c eo f
diterpenoid compounds in the extracts and fractions of A.
senegalensis really correlated well with the high presence of
resins in plants as diterpene acids occur well in plant resins.
Some other published works have reported the isolation of
kaurenoic acid from the leaves of A. senegalensis [34, 35]a n d
aerial parts of Espeletia semigloburata [36] which exhibited
antibacterial, anticancer, anti-inﬂammatory, and antipyretic
eﬀects. The lack of activity against fungal organism, C.
albicans, in the study was in consistent with other reported
work on root bark extract of A. senegalensis which exhibited
lack of activity against C. albicans [16]. In other documented
studies,terpenoidshaveshowntopossessantibacterial[3,37,
38], antiviral [39, 40], and antiprotozoal eﬀects [41]. Par-
ticularly, antibacterial eﬀects of diterpenoids isolated from
other plants have been reported [42, 43]. The results from
this study tend to support the ethnomedicinal claim of root
bark of A. senegalensis in treatment of bacterial infections
and wound healing particularly in the treatment urinary
tract infections in veterinary animals [13]. Furthermore, KA
could equally serve as a veritable lead compound in the
development of potent standard antibacterial agent.
5. Conclusion
Results of the study have indicated that a diterpenoid, kaur-
16-en-19-oic acid or kaurenoic acid, has been identiﬁed as
the phytochemical constituent responsible for the antibacte-
rial eﬀects of root bark of Nigerian Annona senegalensis Pers.
(Verbenaceae)andisdevoidofappreciableantifungaleﬀects.
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